Tnova Pharmaceutical Private Limited

Tnova Pharmaceutical Private Limited - pharma in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U51900KA2022PTC160255 Incorporated 20 April 2022 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹15.47 Lakh
▲ 63% YoY
Net profit · FY 2024
₹26,896
Net margin 1.7%
EBITDA · FY 2024
₹27,128
EBITDA margin 1.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Tnova Pharmaceutical Private Limited

Data last updated:

Tnova Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 April 2022.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51900KA2022PTC160255.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rakhi Kumari and Satish Chandra Jha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O T. Mallikarjun Reddy Flat No 305 3rd Flr Icon Appartment, Bangalore, Karnataka, India – 560037.

As per the financials filed for FY 2024, the company reported a revenue of ₹15.47 Lakh, a growth of 63% compared to the previous year. For the same year it recorded a net profit of ₹26,896 (net margin 1.7%) and EBITDA of ₹27,128 (EBITDA margin 1.8%).

Tnova Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-02-0034161). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51900KA2022PTC160255
Registration Number 160255
Incorporation Date 20 April 2022
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-02-0034161

Recognitions & Rankings of Tnova Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-KR-02-0034161

Contact details

Tnova Pharmaceutical Private Limited's registered office is in Bangalore, Karnataka.

  • Registered Address
    C/O T. Mallikarjun Reddy Flat No 305 3rd Flr Icon Appartment, Bangalore, Karnataka, India – 560037
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Tnova Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Tnova Pharmaceutical is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, scientific and technical activities74Other professional, scientific and technical activities

To see the full business activity and turnover split of Tnova Pharmaceutical Private Limited, buy the company report.

Financials of Tnova Pharmaceutical Private Limited

FY 2025 filings available

Tnova Pharmaceutical Private Limited reported revenue of ₹15.47 Lakh (up 63% YoY) for FY 2024.

Revenue · FY 2024
₹15.47 Lakh ▲ 63%
Net profit · FY 2024
₹26,896 margin 1.7%
EBITDA · FY 2024
₹27,128 margin 1.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 63%
EBITDA CAGR growth
1 year
▲ 439%

Revenue rose 63% in the latest year. EBITDA rose 439% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹27,128
Profit Before Tax
Tax Expense
Net Profit (PAT)₹26,896
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin1.8%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Tnova Pharmaceutical Private Limited, buy the company report.

Board of directors of Tnova Pharmaceutical Private Limited

Tnova Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rakhi KumariDirector20 Apr 20224 Years 6 MonthsCurrent
Satish Chandra JhaDirector20 Apr 20224 Years 6 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Tnova Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Tnova Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Tnova Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Rakhi Kumari was appointed as Director on 20 Apr 2022.

AGM
Tnova Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Tnova Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Rakhi Kumari was appointed as Director.
Appointed
Satish Chandra Jha was appointed as Director.
Incorporation
20 Apr 2022
Tnova Pharmaceutical Private Limited was registered on 20 Apr 2022 with Roc Bangalore & aged 4 years 6 months as per MCA records.

Frequently asked questions

Tnova Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 April 2022 (4+ years old) and is registered under CIN U51900KA2022PTC160255.

Tnova Pharmaceutical has 2 current directors:

The latest financial statements of Tnova Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Tnova Pharmaceutical is U51900KA2022PTC160255. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tnova Pharmaceutical was incorporated on 20 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.

Rakhi Kumari was appointed as Director on 20 Apr 2022. Satish Chandra Jha was appointed as Director on 20 Apr 2022.

Yes, Tnova Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-02-0034161).

The registered office of Tnova Pharmaceutical is at CO T. Mallikarjun Reddy Flat No 305 3rd Flr Icon Appartment, Bangalore, Karnataka, India – 560037.

Tnova Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Tnova Pharmaceutical is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.